FGF12A Regulates Nav1.5 via CaM-regulated and CaM-independent Mechanisms
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
Abstract
Opening
of
the
cardiac
voltage-gated
Na+
channel
(Nav1.5)
is
responsible
for
robust
depolarization
action
potential,
while
inactivation,
which
rapidly
follows,
allows
repolarization.
Regulation
both
voltage-
and
time-dependent
kinetics
Nav1.5
inactivation
can
alter
ability
heart
to
initiate
sustain
a
re-entrant
arrhythmia.
The
C-terminal
domain
(CTD)
has
been
shown
modulate
fast
channel,
multiple
auxiliary
proteins
bind
CTD,
including
calmodulin
(CaM)
intracellular
fibroblast
growth
factor
12A
(FGF12A).
Recently,
non-canonical
CaM-binding
site
was
also
discovered
on
N-terminal
A-splice
variants
iFGFs.
We
performed
cut-open
Vaseline
gap
(COVG)
voltage-clamp
test
whether
FGF12A
with
without
CaM
regulates
gating.
In
WT
channels,
present
had
minimal
effect
voltage
dependence
activation
inactivation.
Conversely,
when
absent
CTD
(IQ/AA),
dramatic
shift
in
steady-state
(SSI)
occurred,
regardless
FGF12A.
These
two
distinct
mechanisms
are
operative
LQT3
mutations
where
requires
voltage-dependence
but
not
inhibit
persistent
late
current.
conclude
that
there
by
modulates
channel:
CaM-regulated
alteration
CaM-independent
inhibition
Language: Английский
Loss of macrophage fibroblast growth factor 12 attenuates cardiac fibrosis in pressure-overloaded myocardium
Santie Li,
No information about this author
Mei Xue,
No information about this author
Junjie Lu
No information about this author
et al.
International Immunopharmacology,
Journal Year:
2025,
Volume and Issue:
154, P. 114614 - 114614
Published: April 7, 2025
Language: Английский
The FGF13‐Caveolin‐1 Axis: A Key Player in the Pathogenesis of Doxorubicin‐ and D‐Galactose‐Induced Premature Cardiac Aging
Enzhao Shen,
No information about this author
Yuecheng Wu,
No information about this author
Weijian Ye
No information about this author
et al.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 4, 2025
Abstract
Delaying
senescence
of
cardiomyocytes
has
garnered
widespread
attention
as
a
potential
target
for
preventing
cardiovascular
diseases
(CVDs).
FGF13
(Fibroblast
growth
factor
13)
been
implicated
in
various
pathophysiological
processes.
However,
its
role
premature
myocardial
aging
and
cardiomyocyte
remains
unknown.
Adeno‐associated
virus
9
(AAV9)
vectors
expressing
cardiac‐specific
Fgf13
knockout
(Fgf13KO)
mice
are
utilized
to
reveal
that
overexpression
deficiency
exacerbated
alleviated
Doxorubicin/D‐galactose‐induced
characteristics
functional
impairment,
respectively.
Transcriptomics
employed
identify
an
association
between
Caveolin‐1
(Cav1).
Mechanistic
studies
indicated
regulated
the
Cav1
promoter
activity
expression
through
p38/MAPK
pathway
nuclear
translocation
p65,
well
binding
level
PTRF
mediate
senescence.
Furthermore,
murine
hearts
reversed
alleviatory
effects
on
phenotype
dysfunction.
This
study
demonstrated
Cav1‐p53‐p21
axis
augment
thereby
cardiac
suggests
knockdown
may
be
promising
approach
combat
CVDs
response
chemotoxicity.
Language: Английский